Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia (Q36794786)
Jump to navigation
Jump to search
scientific article published on 31 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia |
scientific article published on 31 January 2016 |
Statements
1 reference
Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia (English)
1 reference
Manfred Rohde
1 reference
George Sakoulas
1 reference
Monika Kumaraswamy
1 reference
Leo Lin
1 reference
Joshua Olson
1 reference
Poochit Nonejuie
1 reference
Ross Corriden
1 reference
Simon Döhrmann
1 reference
Syed Raza Ali
1 reference
Deirdre Amaro
1 reference
Joe Pogliano
1 reference
31 January 2016
1 reference
1 reference
1264-1269
1 reference
Identifiers
1 reference
1 reference
1 reference